Other
Pap Smear
Pap Smear is an intervention with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
50%(1 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Terminated(1)
Detailed Status
Recruiting2
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
66.7%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (50.0%)
N/A1 (50.0%)
Trials by Status
recruiting240%
completed240%
terminated120%
Recent Activity
2 active trials
Showing 5 of 5
recruiting
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
NCT05049538
recruiting
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
NCT04794322
terminatednot_applicable
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
NCT03606486
completedphase_1
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
NCT01485731
completed
chemQbiosciences:Manual Liquid Based Cytology
NCT01837303
Clinical Trials (5)
Showing 5 of 5 trials
NCT05049538
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
NCT04794322
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
NCT03606486Not Applicable
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
NCT01485731Phase 1
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
NCT01837303
chemQbiosciences:Manual Liquid Based Cytology
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5